Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of HAV and HABV Schedules in Chinese Infants
NCT02445703Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- May 2014
- Primary completion
- Jan 2015
- Modality
- Peptides, Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis A vaccine (inactivated), hepatitis A (inactivated) and hepatitis B (recombinant) vaccine in hepatitis A (HAV), hepatitis B (HBV), sponsored by Sinovac Biotech Ltd.. Started May 2014; status: completed.
02
Drugs
hepatitis A vaccine (inactivated)hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02445703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445703.